Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Complications and reproductive outcome after uterine artery embolization for retained products of conception.

Ohmaru-Nakanishi T, Kuramoto K, Maehara M, Takeuchi R, Oishi H, Ueoka Y.

J Obstet Gynaecol Res. 2019 Oct;45(10):2007-2014. doi: 10.1111/jog.14067. Epub 2019 Jul 23.

PMID:
31338948
2.

Perineal pyoderma gangrenosum in pregnancy: A case report.

Ohmaru-Nakanishi T, Goto H, Maehara M, Oishi H, Ueoka Y.

Case Rep Womens Health. 2019 Mar 7;22:e00102. doi: 10.1016/j.crwh.2019.e00102. eCollection 2019 Apr.

3.

A method of producing genetically manipulated mouse mammary gland.

Tagaya H, Ishikawa K, Hosokawa Y, Kobayashi S, Ueoka Y, Shimada M, Ohashi Y, Mikami H, Yamamoto M, Ihara T, Kumazawa K, Sugihara K, Goshima N, Watanabe S, Semba K.

Breast Cancer Res. 2019 Jan 5;21(1):1. doi: 10.1186/s13058-018-1086-8.

4.

Relationship between social and cognitive functions in people with schizophrenia.

Tominaga T, Tomotake M, Takeda T, Ueoka Y, Tanaka T, Watanabe SY, Kameoka N, Nakataki M, Numata S, Izaki Y, Sumitani S, Kubo H, Kaneda Y, Ohmori T.

Neuropsychiatr Dis Treat. 2018 Aug 30;14:2215-2224. doi: 10.2147/NDT.S171207. eCollection 2018.

5.

Suppression of a single pair of mushroom body output neurons in Drosophila triggers aversive associations.

Ueoka Y, Hiroi M, Abe T, Tabata T.

FEBS Open Bio. 2017 Feb 22;7(4):562-576. doi: 10.1002/2211-5463.12203. eCollection 2017 Apr.

6.

Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.

Yahata H, Kobayashi H, Sonoda K, Shimokawa M, Ohgami T, Saito T, Ogawa S, Sakai K, Ichinoe A, Ueoka Y, Hasuo Y, Nishida M, Masuda S, Kato K.

Int J Clin Oncol. 2016 Jun;21(3):491-7. doi: 10.1007/s10147-015-0928-y. Epub 2015 Dec 10.

PMID:
26662632
7.

Hysteroscopic adhesiolysis for patients with Asherman's syndrome: menstrual and fertility outcomes.

Yamamoto N, Takeuchi R, Izuchi D, Yuge N, Miyazaki M, Yasunaga M, Egashira K, Ueoka Y, Inoue Y.

Reprod Med Biol. 2013 May 5;12(4):159-166. doi: 10.1007/s12522-013-0149-x. eCollection 2013 Oct.

8.

Measurement and Treatment Research toImprove Cognition in Schizophrenia Consensus Cognitive Battery: validation of the Japanese version.

Kaneda Y, Ohmori T, Okahisa Y, Sumiyoshi T, Pu S, Ueoka Y, Takaki M, Nakagome K, Sora I.

Psychiatry Clin Neurosci. 2013 Apr;67(3):182-8. doi: 10.1111/pcn.12029.

9.

Clinical correlates associated with cognitive dysfunction in people with schizophrenia.

Tanaka T, Tomotake M, Ueoka Y, Kaneda Y, Taniguchi K, Nakataki M, Numata S, Tayoshi S, Yamauchi K, Sumitani S, Ohmori T, Ueno S, Ohmori T.

Psychiatry Clin Neurosci. 2012 Oct;66(6):491-8. doi: 10.1111/j.1440-1819.2012.02390.x.

10.

[Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia].

Kaneda Y, Ueoka Y, Sumiyoshi T, Yasui-Furukori N, Ito T, Higuchi Y, Suzuki M, Ohmori T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Nov;31(5-6):259-62. Review. Japanese.

PMID:
22256616
11.

Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia.

Yoshida T, Suga M, Arima K, Muranaka Y, Tanaka T, Eguchi S, Lin C, Yoshida S, Ishikawa M, Higuchi Y, Seo T, Ueoka Y, Tomotake M, Kaneda Y, Darby D, Maruff P, Iyo M, Kasai K, Higuchi T, Sumiyoshi T, Ohmori T, Takahashi K, Hashimoto K.

PLoS One. 2011;6(5):e20469. doi: 10.1371/journal.pone.0020469. Epub 2011 May 26.

12.

Quality of life and cognitive dysfunction in people with schizophrenia.

Ueoka Y, Tomotake M, Tanaka T, Kaneda Y, Taniguchi K, Nakataki M, Numata S, Tayoshi S, Yamauchi K, Sumitani S, Ohmori T, Ueno S, Ohmori T.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):53-9. doi: 10.1016/j.pnpbp.2010.08.018. Epub 2010 Sep 8.

PMID:
20804809
13.

Estimating structure of multivariate systems with genetic algorithms for nonlinear prediction.

Suzuki T, Ueoka Y, Sato H.

Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Dec;80(6 Pt 2):066208. Epub 2009 Dec 17.

PMID:
20365255
14.

Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage.

Kato K, Takao T, Kuboyama A, Tanaka Y, Ohgami T, Yamaguchi S, Adachi S, Yoneda T, Ueoka Y, Kato K, Hayashi S, Asanoma K, Wake N.

Am J Pathol. 2010 Jan;176(1):381-92. doi: 10.2353/ajpath.2010.090056. Epub 2009 Dec 11.

15.

Level of reactive oxygen species induced by p21Waf1/CIP1 is critical for the determination of cell fate.

Inoue T, Kato K, Kato H, Asanoma K, Kuboyama A, Ueoka Y, Yamaguchi S, Ohgami T, Wake N.

Cancer Sci. 2009 Jul;100(7):1275-83. doi: 10.1111/j.1349-7006.2009.01166.x. Epub 2009 Apr 21.

16.

Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.

Ogura T, Kobayashi H, Ueoka Y, Okugawa K, Kato K, Hirakawa T, Hashimoto S, Taniguchi S, Wake N, Nakano H.

Clin Cancer Res. 2006 Sep 1;12(17):5216-23.

17.

Compound heterozygous RDH5 mutations in familial fleck retina with night blindness.

Hayashi T, Goto-Omoto S, Takeuchi T, Gekka T, Ueoka Y, Kitahara K.

Acta Ophthalmol Scand. 2006 Apr;84(2):254-8.

18.

Expression of progesterone receptor B is associated with G0/G1 arrest of the cell cycle and growth inhibition in NIH3T3 cells.

Horiuchi S, Kato K, Suga S, Takahashi A, Ueoka Y, Arima T, Nishida J, Hachisuga T, Kawarabayashi T, Wake N.

Exp Cell Res. 2005 May 1;305(2):233-43.

PMID:
15817149
19.

Four Japanese male patients with juvenile retinoschisis: only three have mutations in the RS1 gene.

Hayashi T, Omoto S, Takeuchi T, Kozaki K, Ueoka Y, Kitahara K.

Am J Ophthalmol. 2004 Nov;138(5):788-98.

PMID:
15531314
20.

Clinical heterogeneity between two Japanese siblings with congenital achromatopsia.

Hayashi T, Kozaki K, Kitahara K, Kubo A, Nishio Y, Omoto S, Nakamura Y, Watanabe A, Toda K, Ueoka Y.

Vis Neurosci. 2004 May-Jun;21(3):413-20.

PMID:
15518223
21.

Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R).

Omoto S, Hayashi T, Kitahara K, Takeuchi T, Ueoka Y.

Ophthalmic Genet. 2004 Jun;25(2):81-90.

PMID:
15370539
22.

K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival.

Ninomiya Y, Kato K, Takahashi A, Ueoka Y, Kamikihara T, Arima T, Matsuda T, Kato H, Nishida J, Wake N.

Cancer Res. 2004 Apr 15;64(8):2759-65.

23.

Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway.

Ueoka Y, Kato K, Wake N.

Mol Cell Endocrinol. 2003 Apr 28;202(1-2):81-8.

PMID:
12770735
24.

Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway.

Kato K, Horiuchi S, Takahashi A, Ueoka Y, Arima T, Matsuda T, Kato H, Nishida Ji J, Nakabeppu Y, Wake N.

J Biol Chem. 2002 Mar 29;277(13):11217-24. Epub 2002 Jan 7.

25.

Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells.

Terao Y, Nishida J, Horiuchi S, Rong F, Ueoka Y, Matsuda T, Kato H, Furugen Y, Yoshida K, Kato K, Wake N.

Int J Cancer. 2001 Oct 15;94(2):257-67.

26.

Observations of vibration shape of AT-cut quartz resonator including electric twins.

Kamiyama E, Itoh T, Murakami Y, Ueoka Y.

IEEE Trans Ultrason Ferroelectr Freq Control. 2001 Jan;48(1):329-32.

PMID:
11367802
27.

Relevance of ER to the Development of Endometrial Hyperplasia and Adenocarcinoma.

Kato K, Horiuchi S, Terao Y, Ueoka Y, Nishida Ji, Mori D, Yoshikawa Y, Wake N.

Breast Cancer. 1999 Oct 25;6(4):312-319.

PMID:
11091736
28.

Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway.

Ueoka Y, Kato K, Kuriaki Y, Horiuchi S, Terao Y, Nishida J, Ueno H, Wake N.

Br J Cancer. 2000 Feb;82(4):891-9.

29.

WAF1 genotype and endometrial cancer susceptibility.

Hachiya T, Kuriaki Y, Ueoka Y, Nishida J, Kato K, Wake N.

Gynecol Oncol. 1999 Feb;72(2):187-92.

PMID:
10021299
30.

Oncogenic Ras modulates epidermal growth factor responsiveness in endometrial carcinomas.

Kato K, Ueoka Y, Kato K, Tamura T, Nishida J, Wake N.

Eur J Cancer. 1998 Apr;34(5):737-44.

PMID:
9713283
31.

CyclinG contributes to G2/M arrest of cells in response to DNA damage.

Shimizu A, Nishida J, Ueoka Y, Kato K, Hachiya T, Kuriaki Y, Wake N.

Biochem Biophys Res Commun. 1998 Jan 26;242(3):529-33.

PMID:
9464250
32.

Contribution of enhanced transcriptional activation by ER to [12Val] K-Ras mediated NIH3T3 cell transformation.

Kato K, Ueoka Y, Kato K, Hachiya T, Nishida J, Wake N.

Oncogene. 1997 Dec 18;15(25):3037-46.

33.

Detection of a cryptic paracentric inversion within band 11p13 in familial aniridia by fluorescence in situ hybridization.

Fukushima Y, Hoovers J, Mannens M, Wakui K, Ohashi H, Ohno T, Ueoka Y, Niikawa N.

Hum Genet. 1993 Apr;91(3):205-9.

PMID:
8478003
34.
35.

Cytochrome c oxidase deficiency with acute onset and rapid recovery.

Nozaki H, Hamano S, Ueoka Y, Horita H, Koga Y, Nonaka I.

Pediatr Neurol. 1990 Sep-Oct;6(5):330-2.

PMID:
2173614
36.

[Crossed "cerebral" diaschisis? Seven cases with unilateral cerebellar vascular lesion which showed decreased perfusion in the contralateral cerebral cortex].

Kimura S, Nakamura H, Matsumura K, Morohashi S, Ueoka Y, Hasegawa A, Yonekura Y.

Kaku Igaku. 1989 Oct;26(10):1259-66. Japanese.

PMID:
2585839
37.
38.

[The physiological analysis of the pupillo-constrictor EMG and the pupillary light reflex in the cat].

Ueoka Y.

Nippon Ganka Gakkai Zasshi. 1986 May;90(5):757-66. Japanese. No abstract available.

PMID:
3751776

Supplemental Content

Support Center